2rl5: Difference between revisions

Revision as of 11:06, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2rl5.png

Template:STRUCTURE 2rl5

Crystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitorCrystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitor

Template:ABSTRACT PUBMED 18311900

About this StructureAbout this Structure

2RL5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis., La DS, Belzile J, Bready JV, Coxon A, Demelfi T, Doerr N, Estrada J, Flynn JC, Flynn SR, Graceffa RF, Harriman SP, Larrow JF, Long AM, Martin MW, Morrison MJ, Patel VF, Roveto PM, Wang L, Weiss MM, Whittington DA, Teffera Y, Zhao Z, Polverino AJ, Harmange JC, J Med Chem. 2008 Mar 27;51(6):1695-705. Epub 2008 Feb 27. PMID:18311900

Page seeded by OCA on Mon Jul 28 11:06:36 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2rl5.jpg|left|200px]]
+{{Seed}}
+[[Image:2rl5.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2rl5|  PDB=2rl5  |  SCENE=  }}
-'''Crystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitor'''
+===Crystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitor===
-==Overview==
+<!--
-Angiogenesis is vital for solid tumor growth, and its prevention is a proven strategy for the treatment of disease states such as cancer. The vascular endothelial growth factor (VEGF) pathway provides several opportunities by which small molecules can act as inhibitors of endothelial proliferation and migration. Critical to these processes is signaling through VEGFR-2 or the kinase insert domain receptor (KDR) upon stimulation by its ligand VEGF. Herein, we report the discovery of 2,3-dihydro-1,4-benzoxazines as inhibitors of intrinsic KDR activity (IC 50 &lt; 0.1 microM) and human umbilical vein endothelial cell (HUVEC) proliferation with IC 50 &lt; 0.1 microM. More specifically, compound 16 was identified as a potent (KDR: &lt; 1 nM and HUVEC: 4 nM) and selective inhibitor that exhibited efficacy in angiogenic in vivo models. In addition, this series of molecules is typically well-absorbed orally, further demonstrating the 2,3-dihydro-1,4-benzoxazine moiety as a promising platform for generating kinase-based antiangiogenic therapeutic agents.
+The line below this paragraph, {{ABSTRACT_PUBMED_18311900}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 18311900 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_18311900}}
 ==About this Structure==
@@ Line 42: / Line 46: @@
 [[Category: Transmembrane]]
 [[Category: Tyrosine-protein kinase]]
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:06:36 2008''